End-stage renal disease and drug-eluting stents: one small step forward.
Gruberg
Luis
L
Division of Invasive Cardiology, Rambam Medical Center and the Bruce-Rappaport Faculty of Medicine, Technion, Israel.
Beyar
Rafael
R
D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation / Q000379:methods; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000628:therapy*; D000077144:Clopidogrel; D023903:Coronary Restenosis / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D015918:Infusion Pumps, Implantable; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D009204:Myocardial Revascularization / Q000295:instrumentation / Q000379:methods; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015995:Prevalence; D006435:Renal Dialysis; D015607:Stents; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine